OGN
Organon & Co
NYSE: OGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$13.34
+0.15% today
Updated 2026-04-29
Market cap
$3.50B
P/E ratio
18.53
P/S ratio
0.56x
EPS (TTM)
$0.72
Dividend yield
2.55%
52W range
$6 – $13
Volume
9.4M
Organon & Co (OGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+3.1%
Last 4 quarters
Revenue YoY growth
-5.3%
Most recent quarter
EPS YoY growth
-30.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.4%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-9.8%
2025-08-05
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-12 | $0.63 | -17.1% | $7.69 | $7.39 | -3.9% |
| 2025-10-30 | $1.01 | +8.6% | $6.34 | $6.75 | +6.5% |
| 2025-08-05 | $1.00 | +6.4% | $9.67 | $8.72 | -9.8% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.76 | $0.63 | -17.1% | $1.51B | -5.3% |
| 2025-09-30 | $0.93 | $1.01 | +8.6% | $1.60B | +1.3% |
| 2025-06-30 | $0.94 | $1.00 | +6.4% | $1.59B | -0.8% |
| 2025-03-31 | $0.89 | $1.02 | +14.6% | $1.51B | -6.7% |
| 2024-12-31 | $0.87 | $0.90 | +3.4% | $1.59B | -0.4% |
| 2024-09-30 | $0.90 | $0.87 | -3.3% | $1.58B | +4.1% |
| 2024-06-30 | $1.08 | $1.12 | +3.7% | $1.61B | -0.1% |
| 2024-03-31 | $0.97 | $1.22 | +25.8% | $1.62B | — |
| 2023-12-31 | $0.83 | $0.88 | +6.0% | $1.60B | — |
| 2023-09-30 | $1.06 | $0.87 | -17.9% | $1.52B | — |
| 2023-06-30 | $1.01 | $1.31 | +29.7% | $1.61B | — |
Frequently asked questions
Has Organon & Co beaten earnings estimates?
Organon & Co has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +3.1% over the last 4 quarters.
How does OGN stock react to earnings?
OGN stock has moved an average of -2.4% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is Organon & Co's revenue growth rate?
Organon & Co reported year-over-year revenue growth of -5.3% in its most recent quarter, with EPS growing -30.0% year-over-year.